iPTH significantly correlated with measures of diastolic dysfunction in patients with non-dialysis chronic kidney disease.
In 2 studies, parathyroid hormone (PTH) values 20 minutes after parathyroidectomy predicted PTH levels for 5 years.
In a study, intact parathyroid hormone levels below 60 and above 1500 pg/mL were associated with nearly double the risk of all-cause mortality.
Patients reported less skin itching, joint pain, and muscle weakness after surgery.
ESRD patients with SHPT undergoing surgery had a 26% lower risk for all-cause mortality compared with medical management.
Single-center study reveals a hospitalization rate of 14% following total parathyroidectomy without autotransplantation.
Bone mineral density in the lumbar spine and femoral neck increased over time in hemodialysis patients who underwent total parathyroidectomy without autotransplantation.
In a study of hemodialysis patients, mortality risk increased along with phosphorus level, particularly among patients with higher residual renal urea clearance.
Dialysis facilities with the least control of PTH, Ca, and P had the greatest risks.
Just 6.7% of patients had target levels of calcium, phosphorus, and parathyroid hormone a year after surgery.
Subtotal parathyroidectomy may lower the death risk of patients with secondary hyperparathyroidism and calciphylaxis.
The surgery reduced the risk of death from any cause by 37%, meta-analysis shows.
SHPT risk was 4 times higher among patients taking furosemide vs hydrochlorothiazide.
Researchers highlighted the benefit of iPTH monitoring.
The debate continues on how best to use parathyroidectomy to treat severe SHPT.
Researchers found insignificant differences between the 2 surgeries in SHPT persistence and recurrence.
Intact parathyroid hormone levels fell significantly in all patients who underwent total Ptx with autotransplant and 91.6% of subtotal Ptx patients.
In a study, ioPTH decay at 30 minutes post-excision was highly accurate in predicting persistent SHPT.
Study finds a 20% to 25% lower risk for early death over the long term.
Postoperative parathyroid hormone levels of 16.6 pg/mL or higher are associated with a 3-fold increased risk of cardiovascular death.
Lowest relative risk of death observed in patients with serum phosphorus and calcium levels of 4.4 mg/dL and 8.8 mg/dL, respectively.
One-third of patients who missed clinical targets for phosphorus, calcium and/or parathormone remained untreated.
A new study suggests that non-oxidized, biologically active PTH testing may help determine mortality risk in hemodialysis patients.
Novel assay can distinguish between oxidized and nonoxidized forms of parathyroid hormone.
Renal and Urology News Articles
- Mediterranean Diet Best for Lowering Aggressive Prostate Cancer Risk
- SABR for Renal Cell Carcinoma Offers Excellent Outcomes
- Radical Cystectomy Offers Better Long-term MIBC Patient Survival
- Robotic Kidney Transplantation Safe, Feasible
- Most CKD Patients With Anemia Show Limited Response to Oral Iron
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)